The project is a 5-year follow-up study of 250 depressed patients aged over 60 years, with similar proportions of early and late onset cases. Detailed psychosocial, functional, clinical, psychiatric, medical, neurologic, cognitive and neuroendocrine assessments will occur at intake and in Years 2 and 4. The principal outcome measures are severity of depressive symptoms, operationally defined remission, relapse and recurrence, functional status and dementia. We will test specific hypotheses in a multifactorial model of risk factors for adverse course of late life depression. The primary factors are psychosocial, brain structural change, and neuroendocrine dysfunctions, with medical illness and clinical features as covariates. The project will advance on past work by becoming rigorous medical and psychiatric assessments with psychosocial and psychobiologic perspectives. In a naturalistic study design we will test specific hypotheses about the salience and interactions of variables in each dimension for prognosis. Major hypotheses to be tested for risk of adverse outcome in each dimension for prognosis. Major hypotheses to be tested for risk of adverse outcome include differential course of early versus late onset cases; the moderating role of social support; cerebral vascular risk factors, including Apolipoprotein E4; brain pathology evident on MRI; and dementia related to abnormal DST status. Statistical analyses will include hierarchical linear regression models for main effects and interactions. Results of the project will clarify emerging concepts of a proposed vascular etiology depression in late life; will identify factors associated with delayed response to treatment and with relapses; will provide needed information on the timing of relapses in relation to changing social support in the elderly. Results in this clinical population will be valuable for comparison with epidemiological data. This project benefits from the resources of the Duke Mental Health Clinical Research Center for essential support.
| Deng, Yi; McQuoid, Douglas R; Potter, Guy G et al. (2018) Predictors of recurrence in remitted late-life depression. Depress Anxiety 35:658-667 |
| Rajkowska, Grazyna; Mahajan, Gouri; Legutko, Beata et al. (2017) Length of axons expressing the serotonin transporter in orbitofrontal cortex is lower with age in depression. Neuroscience 359:30-39 |
| Riddle, Meghan; Potter, Guy G; McQuoid, Douglas R et al. (2017) Longitudinal Cognitive Outcomes of Clinical Phenotypes of Late-Life Depression. Am J Geriatr Psychiatry 25:1123-1134 |
| Johnson, Anne D; McQuoid, Douglas R; Steffens, David C et al. (2017) Effects of stressful life events on cerebral white matter hyperintensity progression. Int J Geriatr Psychiatry 32:e10-e17 |
| Manning, Kevin J; Chan, Grace; Steffens, David C (2017) Neuroticism Traits Selectively Impact Long Term Illness Course and Cognitive Decline in Late-Life Depression. Am J Geriatr Psychiatry 25:220-229 |
| Rubinow, Marisa J; Mahajan, Gouri; May, Warren et al. (2016) Basolateral amygdala volume and cell numbers in major depressive disorder: a postmortem stereological study. Brain Struct Funct 221:171-84 |
| Hybels, Celia F; Pieper, Carl F; Blazer, Dan G et al. (2016) Heterogeneity in the three-year course of major depression among older adults. Int J Geriatr Psychiatry 31:775-82 |
| Hybels, Celia F; Pieper, Carl F; Payne, Martha E et al. (2016) Late-life Depression Modifies the Association Between Cerebral White Matter Hyperintensities and Functional Decline Among Older Adults. Am J Geriatr Psychiatry 24:42-49 |
| Saha, Sayoni; Hatch, Daniel J; Hayden, Kathleen M et al. (2016) Appetite and Weight Loss Symptoms in Late-Life Depression Predict Dementia Outcomes. Am J Geriatr Psychiatry 24:870-8 |
| Potter, Guy G; McQuoid, Douglas R; Whitson, Heather E et al. (2016) Physical frailty in late-life depression is associated with deficits in speed-dependent executive functions. Int J Geriatr Psychiatry 31:466-74 |
Showing the most recent 10 out of 159 publications
